Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Axatilimab |
| Trade Name | Niktimvo |
| Synonyms | SNDX 6352|SNDX6352|UCB6352|SNDX-6352 |
| Drug Descriptions |
Niktimvo (axatilimab) is a humanized monoclonal antibody against colony-stimulating factor-1 receptor (CSF-1R), which may enhance anti-tumor immune response (SITC Meeting, Nov 2017, abstract P505). Niktimvo (axatilimab) is FDA-approved for the treatment of chronic graft-versus-host disease (FDA.gov) |
| DrugClasses | CSF1R Antibody 5 |
| CAS Registry Number | 2155851-88-8 |
| NCIT ID | C155813 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Axatilimab | Axatilimab | 0 | 3 |
| Axatilimab + Azacitidine | Axatilimab Azacitidine | 0 | 1 |
| Axatilimab + Cyclophosphamide + Retifanlimab | Axatilimab Cyclophosphamide Retifanlimab | 0 | 1 |
| Axatilimab + Durvalumab | Axatilimab Durvalumab | 0 | 2 |
| Axatilimab + Nivolumab | Axatilimab Nivolumab | 0 | 1 |
| Axatilimab + Olaparib | Axatilimab Olaparib | 0 | 1 |
| Axatilimab + Paclitaxel + Retifanlimab | Axatilimab Paclitaxel Retifanlimab | 0 | 1 |
| Axatilimab + Pembrolizumab | Axatilimab Pembrolizumab | 0 | 2 |
| Axatilimab + Ruxolitinib | Axatilimab Ruxolitinib | 0 | 1 |